Pancrelipases, Xerese Cream Returned for Routine Monitoring Medscape January 30, 2012 — Three forms of pancrelipase and an acyclovir/hydrocortisone cream were recommended for return to routine monitoring during an abbreviated review as part of the US Food and Drug Administration (FDA) Pediatric Advisory Committee ... |
